JDOCvsRXL
JPMorgan Healthcare Leaders ETF against ProShares Ultra Health Care — the fee, the flows, the book, and a year head-to-head.
Head to head
| JDOC | RXL | |
|---|---|---|
| Expense ratio | 0.65% | 0.95% |
| Assets | $9048.54T | $99M |
| Net flow, 1 month | — | +$1M |
| Net flow, 1 year | −$25K | +$3M |
| Return, YTD | +2.9% | +13.8% |
| Return, 1 year | +10.6% | +31.2% |
| Avg daily volume | 241 | 9K |
| Holdings | 67 | 73 |
| Listed | Oct 31, 2023 | Feb 1, 2007 |
| Options market | No | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS